BioCentury | Sep 19, 2019
Translation in Brief

Public funding highlights

...and Infectious Diseases (NIAID) awarded $41.6 million over five years to University of Connecticut , The Henry M. Jackson Foundation...
BioCentury | Aug 7, 2014
Distillery Therapeutics

Indication: Infectious disease

...technology. SciBX 7(30); doi:10.1038/scibx.2014.895 Published online Aug. 7, 2014 Patented; m102.4 available for licensing from the Henry M. Jackson Foundation...
BioCentury | Aug 2, 2012
Distillery Techniques

Technology: Drug platforms

...planned. SciBX 5(30); doi:10.1038/scibx.2012.797 Published online Aug. 2, 2012 Patent pending; available for licensing from the Henry M. Jackson Foundation...
BioCentury | Dec 5, 2011
Company News

Galena Biopharma, Roche deal

...monotherapy. The trial, which is expected to start next half, will also be sponsored by the Henry M. Jackson Foundation...
BioCentury | Sep 26, 2011
Finance

Highlights of weekly biotech stock moves

...12%) to $0.99 last week after the University of Texas M.D. Anderson Cancer Center and the Henry M. Jackson Foundation...
BioCentury | Sep 26, 2011
Company News

RXi Pharmaceuticals, The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., University of Texas M.D. Anderson Cancer Center deal

...EGFR2 ; HER2 ; ErbB2 ; neu) and sargramostim. RXi Pharmaceuticals Corp. (NASDAQ:RXII), Worcester, Mass The Henry M. Jackson Foundation...
BioCentury | Jul 18, 2011
Company News

RXi Pharmaceuticals, The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. deal

...is majority owned by Roche, markets Herceptin in Japan. RXi Pharmaceuticals Corp. (NASDAQ:RXII), Worcester, Mass. The Henry M. Jackson Foundation...
BioCentury | Feb 19, 2009
Distillery Therapeutics

Indication: Neurology

...Published online Feb. 19, 2009 PCT patent application filed; available for licensing Contact: Carol Lavrich, The Henry M. Jackson Foundation...
Items per page:
1 - 8 of 8
BioCentury | Sep 19, 2019
Translation in Brief

Public funding highlights

...and Infectious Diseases (NIAID) awarded $41.6 million over five years to University of Connecticut , The Henry M. Jackson Foundation...
BioCentury | Aug 7, 2014
Distillery Therapeutics

Indication: Infectious disease

...technology. SciBX 7(30); doi:10.1038/scibx.2014.895 Published online Aug. 7, 2014 Patented; m102.4 available for licensing from the Henry M. Jackson Foundation...
BioCentury | Aug 2, 2012
Distillery Techniques

Technology: Drug platforms

...planned. SciBX 5(30); doi:10.1038/scibx.2012.797 Published online Aug. 2, 2012 Patent pending; available for licensing from the Henry M. Jackson Foundation...
BioCentury | Dec 5, 2011
Company News

Galena Biopharma, Roche deal

...monotherapy. The trial, which is expected to start next half, will also be sponsored by the Henry M. Jackson Foundation...
BioCentury | Sep 26, 2011
Finance

Highlights of weekly biotech stock moves

...12%) to $0.99 last week after the University of Texas M.D. Anderson Cancer Center and the Henry M. Jackson Foundation...
BioCentury | Sep 26, 2011
Company News

RXi Pharmaceuticals, The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc., University of Texas M.D. Anderson Cancer Center deal

...EGFR2 ; HER2 ; ErbB2 ; neu) and sargramostim. RXi Pharmaceuticals Corp. (NASDAQ:RXII), Worcester, Mass The Henry M. Jackson Foundation...
BioCentury | Jul 18, 2011
Company News

RXi Pharmaceuticals, The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. deal

...is majority owned by Roche, markets Herceptin in Japan. RXi Pharmaceuticals Corp. (NASDAQ:RXII), Worcester, Mass. The Henry M. Jackson Foundation...
BioCentury | Feb 19, 2009
Distillery Therapeutics

Indication: Neurology

...Published online Feb. 19, 2009 PCT patent application filed; available for licensing Contact: Carol Lavrich, The Henry M. Jackson Foundation...
Items per page:
1 - 8 of 8